{"id":90145,"date":"2026-01-08T03:48:28","date_gmt":"2026-01-07T18:48:28","guid":{"rendered":"https:\/\/www.marketresearch.co.jp\/insights\/hospital-infection-therapeutics-market-mordor\/"},"modified":"2026-04-03T19:25:43","modified_gmt":"2026-04-03T10:25:43","slug":"hospital-infection-therapeutics-market-mordor","status":"publish","type":"post","link":"https:\/\/www.marketresearch.co.jp\/insights\/hospital-infection-therapeutics-market-mordor\/","title":{"rendered":"\u9662\u5185\u611f\u67d3\u6cbb\u7642\u5e02\u5834\u898f\u6a21\u30fb\u30b7\u30a7\u30a2\u5206\u6790 &#8211; \u6210\u9577\u52d5\u5411\u3068\u4e88\u6e2c (2025-2030\u5e74)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.marketresearch.co.jp\/insights\/wp-content\/uploads\/2026\/01\/hospital-infection-therapeutics-market_1675951182865_Picture2-scaled.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.marketresearch.co.jp\/insights\/wp-content\/uploads\/2026\/01\/hospital-infection-therapeutics-market-size-image-1751374195889.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">1. \u306f\u3058\u3081\u306b<\/p>\n<ul>\n<li class=\"toc-level-2\">1.1 \u8abf\u67fb\u306e\u524d\u63d0\u3068\u5e02\u5834\u306e\u5b9a\u7fa9<\/li>\n<li class=\"toc-level-2\">1.2 \u8abf\u67fb\u7bc4\u56f2<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">2. \u8abf\u67fb\u65b9\u6cd5<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">3. \u30a8\u30b0\u30bc\u30af\u30c6\u30a3\u30d6\u30b5\u30de\u30ea\u30fc<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">4. \u5e02\u5834\u6982\u6cc1<\/p>\n<ul>\n<li class=\"toc-level-2\">4.1 \u5e02\u5834\u6982\u8981<\/li>\n<li class=\"toc-level-2\">4.2 \u5e02\u5834\u306e\u63a8\u9032\u8981\u56e0\n<ul>\n<li class=\"toc-level-3\">4.2.1 \u533b\u7642\u95a2\u9023\u611f\u67d3\u75c7\uff08HAIs\uff09\u306e\u8513\u5ef6\u306e\u5897\u52a0<\/li>\n<li class=\"toc-level-3\">4.2.2 \u5916\u79d1\u624b\u8853\u4ef6\u6570\u306e\u5897\u52a0<\/li>\n<li class=\"toc-level-3\">4.2.3 \u6297\u83cc\u85ac\u8010\u6027\u5371\u6a5f\u306e\u9ad8\u307e\u308a<\/li>\n<li class=\"toc-level-3\">4.2.4 \u65b0\u898f\u6297\u751f\u7269\u8cea\u306b\u5bfe\u3059\u308b\u653f\u5e9c\u306e\u30b5\u30d6\u30b9\u30af\u30ea\u30d7\u30b7\u30e7\u30f3\u30a4\u30f3\u30bb\u30f3\u30c6\u30a3\u30d6<\/li>\n<li class=\"toc-level-3\">4.2.5 AI\u3092\u6d3b\u7528\u3057\u305f\u8fc5\u901f\u306a\u6297\u751f\u7269\u8cea\u767a\u898b<\/li>\n<li class=\"toc-level-3\">4.2.6 \u611f\u67d3\u75c7\u76e3\u8996\u5206\u6790\u306e\u5c0e\u5165<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.3 \u5e02\u5834\u306e\u963b\u5bb3\u8981\u56e0\n<ul>\n<li class=\"toc-level-3\">4.3.1 \u6297\u83cc\u85ac\u8010\u6027\uff08AMR\uff09\u306e\u52a0\u901f\u306b\u3088\u308b\u85ac\u5264\u52b9\u679c\u306e\u4f4e\u4e0b<\/li>\n<li class=\"toc-level-3\">4.3.2 \u9ad8\u3044\u958b\u767a\u30b3\u30b9\u30c8\u3068\u9577\u671f\u306b\u308f\u305f\u308b\u6cbb\u9a13<\/li>\n<li class=\"toc-level-3\">4.3.3 \u85ac\u5264\u9700\u8981\u3092\u6291\u5236\u3059\u308b\u4e88\u9632\u6280\u8853<\/li>\n<li class=\"toc-level-3\">4.3.4 \u6297\u751f\u7269\u8cea\u88fd\u9020\u306b\u304a\u3051\u308b\u53b3\u3057\u3044\u6392\u51fa\u898f\u5236<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.4 \u898f\u5236\u74b0\u5883<\/li>\n<li class=\"toc-level-2\">4.5 \u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u5206\u6790<\/li>\n<li class=\"toc-level-2\">4.6 \u30dd\u30fc\u30bf\u30fc\u306e5\u3064\u306e\u529b\u5206\u6790\n<ul>\n<li class=\"toc-level-3\">4.6.1 \u65b0\u898f\u53c2\u5165\u306e\u8105\u5a01<\/li>\n<li class=\"toc-level-3\">4.6.2 \u8cb7\u3044\u624b\u306e\u4ea4\u6e09\u529b<\/li>\n<li class=\"toc-level-3\">4.6.3 \u4f9b\u7d66\u8005\u306e\u4ea4\u6e09\u529b<\/li>\n<li class=\"toc-level-3\">4.6.4 \u4ee3\u66ff\u54c1\u306e\u8105\u5a01<\/li>\n<li class=\"toc-level-3\">4.6.5 \u7af6\u4e89\u4e0a\u306e\u5bfe\u7acb<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">5. \u5e02\u5834\u898f\u6a21\u3068\u6210\u9577\u4e88\u6e2c\uff08\u91d1\u984d\uff09<\/p>\n<ul>\n<li class=\"toc-level-2\">5.1 \u85ac\u5264\u30af\u30e9\u30b9\u5225\n<ul>\n<li class=\"toc-level-3\">5.1.1 \u6297\u83cc\u85ac<\/li>\n<li class=\"toc-level-3\">5.1.2 \u6297\u771f\u83cc\u85ac<\/li>\n<li class=\"toc-level-3\">5.1.3 \u6297\u30a6\u30a4\u30eb\u30b9\u85ac<\/li>\n<li class=\"toc-level-3\">5.1.4 \u305d\u306e\u4ed6<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.2 \u611f\u67d3\u75c7\u30bf\u30a4\u30d7\u5225\n<ul>\n<li class=\"toc-level-3\">5.2.1 \u8840\u6d41\u611f\u67d3\u75c7<\/li>\n<li class=\"toc-level-3\">5.2.2 \u5c3f\u8def\u611f\u67d3\u75c7<\/li>\n<li class=\"toc-level-3\">5.2.3 \u624b\u8853\u90e8\u4f4d\u611f\u67d3\u75c7<\/li>\n<li class=\"toc-level-3\">5.2.4 \u80ba\u708e (HAP\/VAP)<\/li>\n<li class=\"toc-level-3\">5.2.5 \u305d\u306e\u4ed6<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.3 \u6295\u4e0e\u7d4c\u8def\u5225\n<ul>\n<li class=\"toc-level-3\">5.3.1 \u7d4c\u53e3<\/li>\n<li class=\"toc-level-3\">5.3.2 \u9759\u8108\u5185<\/li>\n<li class=\"toc-level-3\">5.3.3 \u305d\u306e\u4ed6<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.4 \u5730\u57df\u5225\n<ul>\n<li class=\"toc-level-3\">5.4.1 \u5317\u7c73<\/li>\n<li class=\"toc-level-4\">5.4.1.1 \u7c73\u56fd<\/li>\n<li class=\"toc-level-4\">5.4.1.2 \u30ab\u30ca\u30c0<\/li>\n<li class=\"toc-level-4\">5.4.1.3 \u30e1\u30ad\u30b7\u30b3<\/li>\n<li class=\"toc-level-3\">5.4.2 \u6b27\u5dde<\/li>\n<li class=\"toc-level-4\">5.4.2.1 \u30c9\u30a4\u30c4<\/li>\n<li class=\"toc-level-4\">5.4.2.2 \u82f1\u56fd<\/li>\n<li class=\"toc-level-4\">5.4.2.3 \u30d5\u30e9\u30f3\u30b9<\/li>\n<li class=\"toc-level-4\">5.4.2.4 \u30a4\u30bf\u30ea\u30a2<\/li>\n<li class=\"toc-level-4\">5.4.2.5 \u30b9\u30da\u30a4\u30f3<\/li>\n<li class=\"toc-level-4\">5.4.2.6 \u305d\u306e\u4ed6\u306e\u6b27\u5dde<\/li>\n<li class=\"toc-level-3\">5.4.3 \u30a2\u30b8\u30a2\u592a\u5e73\u6d0b<\/li>\n<li class=\"toc-level-4\">5.4.3.1 \u4e2d\u56fd<\/li>\n<li class=\"toc-level-4\">5.4.3.2 \u65e5\u672c<\/li>\n<li class=\"toc-level-4\">5.4.3.3 \u30a4\u30f3\u30c9<\/li>\n<li class=\"toc-level-4\">5.4.3.4 \u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2<\/li>\n<li class=\"toc-level-4\">5.4.3.5 \u97d3\u56fd<\/li>\n<li class=\"toc-level-4\">5.4.3.6 \u305d\u306e\u4ed6\u306e\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b<\/li>\n<li class=\"toc-level-3\">5.4.4 \u4e2d\u6771\u304a\u3088\u3073\u30a2\u30d5\u30ea\u30ab<\/li>\n<li class=\"toc-level-4\">5.4.4.1 GCC<\/li>\n<li class=\"toc-level-4\">5.4.4.2 \u5357\u30a2\u30d5\u30ea\u30ab<\/li>\n<li class=\"toc-level-4\">5.4.4.3 \u305d\u306e\u4ed6\u306e\u4e2d\u6771\u304a\u3088\u3073\u30a2\u30d5\u30ea\u30ab<\/li>\n<li class=\"toc-level-3\">5.4.5 \u5357\u7c73<\/li>\n<li class=\"toc-level-4\">5.4.5.1 \u30d6\u30e9\u30b8\u30eb<\/li>\n<li class=\"toc-level-4\">5.4.5.2 \u30a2\u30eb\u30bc\u30f3\u30c1\u30f3<\/li>\n<li class=\"toc-level-4\">5.4.5.3 \u305d\u306e\u4ed6\u306e\u5357\u7c73<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">6. \u7af6\u5408\u60c5\u52e2<\/p>\n<ul>\n<li class=\"toc-level-2\">6.1 \u5e02\u5834\u96c6\u4e2d\u5ea6<\/li>\n<li class=\"toc-level-2\">6.2 \u5e02\u5834\u30b7\u30a7\u30a2\u5206\u6790<\/li>\n<li class=\"toc-level-2\">6.3 \u4f01\u696d\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\uff08\u30b0\u30ed\u30fc\u30d0\u30eb\u6982\u8981\u3001\u5e02\u5834\u6982\u8981\u3001\u4e3b\u8981\u30bb\u30b0\u30e1\u30f3\u30c8\u3001\u5229\u7528\u53ef\u80fd\u306a\u8ca1\u52d9\u60c5\u5831\u3001\u6226\u7565\u60c5\u5831\u3001\u4e3b\u8981\u4f01\u696d\u306e\u5e02\u5834\u9806\u4f4d\/\u30b7\u30a7\u30a2\u3001\u88fd\u54c1\u30fb\u30b5\u30fc\u30d3\u30b9\u3001\u304a\u3088\u3073\u6700\u8fd1\u306e\u52d5\u5411\u3092\u542b\u3080\uff09\n<ul>\n<li class=\"toc-level-3\">6.3.1 AbbVie Inc.<\/li>\n<li class=\"toc-level-3\">6.3.2 Merck &amp; Co., Inc.<\/li>\n<li class=\"toc-level-3\">6.3.3 Teva Pharmaceutical Industries Ltd.<\/li>\n<li class=\"toc-level-3\">6.3.4 Viatris Inc.<\/li>\n<li class=\"toc-level-3\">6.3.5 F. Hoffmann-La Roche AG<\/li>\n<li class=\"toc-level-3\">6.3.6 Bayer AG<\/li>\n<li class=\"toc-level-3\">6.3.7 GlaxoSmithKline plc<\/li>\n<li class=\"toc-level-3\">6.3.8 Aurobindo Pharma Ltd (Eugia)<\/li>\n<li class=\"toc-level-3\">6.3.9 Sanofi S.A.<\/li>\n<li class=\"toc-level-3\">6.3.10 Pfizer Inc.<\/li>\n<li class=\"toc-level-3\">6.3.11 Melinta Therapeutics<\/li>\n<li class=\"toc-level-3\">6.3.12 Hikma Pharmaceuticals PLC<\/li>\n<li class=\"toc-level-3\">6.3.13 Glenmark Pharmaceuticals Ltd.<\/li>\n<li class=\"toc-level-3\">6.3.14 Basilea Pharmaceutica Ltd.<\/li>\n<li class=\"toc-level-3\">6.3.15 \u5869\u91ce\u7fa9\u88fd\u85ac\u682a\u5f0f\u4f1a\u793e<\/li>\n<li class=\"toc-level-3\">6.3.16 Paratek Pharmaceuticals Inc.<\/li>\n<li class=\"toc-level-3\">6.3.17 Spero Therapeutics Inc.<\/li>\n<li class=\"toc-level-3\">6.3.18 Iterum Therapeutics plc<\/li>\n<li class=\"toc-level-3\">6.3.19 Theravance Biopharma, Inc.<\/li>\n<li class=\"toc-level-3\">6.3.20 Cipla Ltd.<\/li>\n<li class=\"toc-level-3\">6.3.21 Seres Therapeutics Inc.<\/li>\n<li class=\"toc-level-3\">6.3.22 Venatorx Pharmaceuticals Inc.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">7. \u5e02\u5834\u6a5f\u4f1a\u3068\u5c06\u6765\u5c55\u671b<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u75c5\u9662\u611f\u67d3\u6cbb\u7642\u85ac\u5e02\u5834\u306e\u6982\u8981<\/p>\n<p>\u672c\u30ec\u30dd\u30fc\u30c8\u306f\u3001\u75c5\u9662\u611f\u67d3\u6cbb\u7642\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3001\u6210\u9577\u50be\u5411\u3001\u304a\u3088\u30732025\u5e74\u304b\u30892030\u5e74\u307e\u3067\u306e\u4e88\u6e2c\u306b\u3064\u3044\u3066\u8a73\u7d30\u306b\u5206\u6790\u3057\u305f\u3082\u306e\u3067\u3059\u3002<\/p>\n<p>\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c<br \/>\n\u75c5\u9662\u611f\u67d3\u6cbb\u7642\u85ac\u5e02\u5834\u306f\u30012025\u5e74\u306b\u306f119.1\u5104\u7c73\u30c9\u30eb\u3068\u63a8\u5b9a\u3055\u308c\u30012030\u5e74\u306b\u306f140.2\u5104\u7c73\u30c9\u30eb\u306b\u9054\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u4e88\u6e2c\u671f\u9593\uff082025\u5e74\uff5e2030\u5e74\uff09\u306b\u304a\u3051\u308b\u5e74\u5e73\u5747\u6210\u9577\u7387\uff08CAGR\uff09\u306f3.32%\u3067\u3059\u3002\u533b\u7642\u95a2\u9023\u611f\u67d3\u75c7\uff08HAI\uff09\u306e\u767a\u751f\u7387\u4e0a\u6607\u304c\u9700\u8981\u3092\u727d\u5f15\u3057\u3066\u3044\u307e\u3059\u304c\u3001\u611f\u67d3\u4e88\u9632\u6280\u8853\u306e\u666e\u53ca\u304c\u6210\u9577\u306e\u53ef\u80fd\u6027\u3092\u6291\u5236\u3059\u308b\u8981\u56e0\u3068\u3082\u306a\u3063\u3066\u3044\u307e\u3059\u3002\u30ab\u30eb\u30d0\u30da\u30cd\u30e0\u8010\u6027\u30a2\u30b7\u30cd\u30c8\u30d0\u30af\u30bf\u30fc\u30fb\u30d0\u30a6\u30de\u30cb\u306b\u3088\u308b\u6b7b\u4ea1\u7387\u306f\u96c6\u4e2d\u6cbb\u7642\u5ba4\u306740%\u3092\u8d85\u3048\u3066\u304a\u308a\u3001\u52b9\u679c\u7684\u306a\u85ac\u5264\u306e\u7dca\u6025\u6027\u304c\u9ad8\u307e\u3063\u3066\u3044\u307e\u3059\u3002\u5404\u56fd\u653f\u5e9c\u306f\u6297\u83cc\u85ac\u958b\u767a\u306b\u65b0\u305f\u306a\u8cc7\u91d1\u3092\u6295\u5165\u3057\u3066\u304a\u308a\u3001\u4f8b\u3048\u3070BARDA\u306f2024\u5e74\u306b\u8010\u6027\u5bfe\u7b56\u306b5\u5104\u7c73\u30c9\u30eb\u4ee5\u4e0a\u3092\u62e0\u51fa\u3057\u307e\u3057\u305f\u3002\u307e\u305f\u3001AI\u3092\u6d3b\u7528\u3057\u305f\u5275\u85ac\u306e\u9032\u5c55\u304c\u8cc7\u7523\u7279\u5b9a\u3092\u52a0\u901f\u3055\u305b\u3001PASTEUR\u6cd5\u306e\u3088\u3046\u306a\u30b5\u30d6\u30b9\u30af\u30ea\u30d7\u30b7\u30e7\u30f3\u578b\u511f\u9084\u63d0\u6848\u306f\u3001\u30a4\u30ce\u30d9\u30fc\u30bf\u30fc\u306b\u3068\u3063\u3066\u5b89\u5b9a\u3057\u305f\u53ce\u76ca\u306e\u898b\u901a\u3057\u3092\u3082\u305f\u3089\u3059\u3068\u671f\u5f85\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u4e3b\u8981\u306a\u30ec\u30dd\u30fc\u30c8\u306e\u30dd\u30a4\u30f3\u30c8<br \/>\n*   \u85ac\u5264\u30af\u30e9\u30b9\u5225: 2024\u5e74\u306b\u306f\u6297\u83cc\u85ac\u304c\u53ce\u76ca\u30b7\u30a7\u30a2\u306e72.21%\u3092\u5360\u3081\u3001\u6297\u30a6\u30a4\u30eb\u30b9\u85ac\u306f2030\u5e74\u307e\u3067\u306b3.83%\u306eCAGR\u3067\u62e1\u5927\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u611f\u67d3\u30bf\u30a4\u30d7\u5225: 2024\u5e74\u306b\u306f\u8840\u6d41\u611f\u67d3\u75c7\u304c\u75c5\u9662\u611f\u67d3\u6cbb\u7642\u85ac\u5e02\u5834\u30b7\u30a7\u30a2\u306e30.65%\u3092\u5360\u3081\u3001\u624b\u8853\u90e8\u4f4d\u611f\u67d3\u75c7\u306f2030\u5e74\u307e\u3067\u306b3.54%\u306eCAGR\u3067\u5897\u52a0\u3059\u308b\u3068\u898b\u8fbc\u307e\u308c\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u6295\u4e0e\u7d4c\u8def\u5225: 2024\u5e74\u306b\u306f\u9759\u8108\u5185\u6295\u4e0e\u88fd\u54c1\u304c\u75c5\u9662\u611f\u67d3\u6cbb\u7642\u85ac\u5e02\u5834\u898f\u6a21\u306e44.95%\u3092\u5360\u3081\u3001\u7d4c\u53e3\u88fd\u5264\u306f2025\u5e74\u304b\u30892030\u5e74\u306e\u9593\u306b4.13%\u306eCAGR\u3067\u9032\u5c55\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u5730\u57df\u5225: 2024\u5e74\u306b\u306f\u5317\u7c73\u304c\u53ce\u76ca\u306e37.83%\u3092\u5360\u3081\u3001\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df\u306f2030\u5e74\u307e\u3067\u306b\u6700\u901f\u306e4.53%\u306eCAGR\u3092\u8a18\u9332\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u5e02\u5834\u306e\u30c8\u30ec\u30f3\u30c9\u3068\u6d1e\u5bdf\uff08\u4fc3\u9032\u8981\u56e0\uff09<br \/>\n\u5e02\u5834\u306e\u6210\u9577\u3092\u727d\u5f15\u3059\u308b\u4e3b\u306a\u8981\u56e0\u306f\u4ee5\u4e0b\u306e\u901a\u308a\u3067\u3059\u3002<br \/>\n1.  HAI\u306e\u8513\u5ef6\u62e1\u5927\uff08CAGR\u3078\u306e\u5f71\u97ff: +0.8%\uff09: \u7c73\u56fd\u3067\u306f\u5165\u9662\u60a3\u8005\u306e\u7d0431\u4eba\u306b1\u4eba\u304c\u6bce\u65e5HAI\u306b\u7f79\u60a3\u3057\u3001\u8840\u6d41\u611f\u67d3\u75c7\u3060\u3051\u3067\u3082\u5e74\u959371,000\u4eba\u4ee5\u4e0a\u306e\u6b7b\u4ea1\u306b\u3064\u306a\u304c\u3063\u3066\u3044\u307e\u3059\u3002\u8d85\u75c5\u539f\u6027\u30ab\u30eb\u30d0\u30da\u30cd\u30e0\u8010\u6027\u80ba\u708e\u687f\u83cc\u682a\u306f\u3001\u514d\u75ab\u4e0d\u5168\u60a3\u8005\u3060\u3051\u3067\u306a\u304f\u5065\u5eb7\u306a\u500b\u4eba\u306b\u3082\u611f\u67d3\u3057\u3001\u5f93\u6765\u306e\u6297\u83cc\u85ac\u6cbb\u7642\u3092\u56f0\u96e3\u306b\u3057\u3066\u3044\u307e\u3059\u3002\u7279\u306b\u4e2d\u56fd\u5357\u897f\u90e8\u306e\u4e09\u6b21\u75c5\u9662\u3067\u306f\u3001\u8840\u6db2\u5185\u79d1\u3001\u5faa\u74b0\u5668\u5185\u79d1\u3001\u795e\u7d4c\u5185\u79d1\u75c5\u68df\u3067HAI\u306e\u767a\u751f\u7387\u304c\u6700\u3082\u9ad8\u304f\u3001\u80ba\u708e\u687f\u83cc\u3068\u5927\u8178\u83cc\u304c\u512a\u52e2\u3067\u3059\u3002\u3053\u308c\u3089\u306e\u30d1\u30bf\u30fc\u30f3\u306f\u3001\u5f37\u529b\u306a\u5e83\u57df\u30b9\u30da\u30af\u30c8\u30eb\u85ac\u5264\u306b\u5bfe\u3059\u308b\u4e16\u754c\u7684\u306a\u30cb\u30fc\u30ba\u3092\u5f37\u5316\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n2.  \u5916\u79d1\u624b\u8853\u4ef6\u6570\u306e\u5897\u52a0\uff08CAGR\u3078\u306e\u5f71\u97ff: +0.6%\uff09: \u5916\u6765\u624b\u8853\u30bb\u30f3\u30bf\u30fc\u3067\u306f\u3001CDC\u304c\u7fa9\u52d9\u4ed8\u3051\u308b\u76e3\u8996\u30d7\u30ed\u30c8\u30b3\u30eb\u306b\u57fa\u3065\u304d\u3001\u4f55\u767e\u4e07\u4ef6\u3082\u306e\u5916\u6765\u624b\u8853\u304c\u884c\u308f\u308c\u3001\u624b\u8853\u90e8\u4f4d\u611f\u67d3\u75c7\uff08SSI\uff09\u306e\u65e9\u671f\u767a\u898b\u3092\u4fc3\u9032\u3057\u3066\u3044\u307e\u3059\u3002\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df\u3067\u306f\u3001\u30a4\u30f3\u30d5\u30e9\u6574\u5099\u3068\u9ad8\u9f62\u5316\u4eba\u53e3\u306b\u3088\u308b\u8907\u96d1\u306a\u4ecb\u5165\u306e\u5897\u52a0\u306b\u3088\u308a\u3001\u624b\u8853\u4ef6\u6570\u304c\u6700\u3082\u6025\u5897\u3057\u3066\u3044\u307e\u3059\u3002\u8170\u690e\u304a\u3088\u3073\u80f8\u8170\u690e\u624b\u8853\u306fSSI\u306e\u30ea\u30b9\u30af\u4e0a\u6607\u3068\u95a2\u9023\u3057\u3066\u304a\u308a\u3001\u7279\u306b\u8853\u524d48\u6642\u9593\u4ee5\u5185\u306b\u5165\u9662\u3057\u305f\u60a3\u8005\u3067\u9855\u8457\u3067\u3059\u3002<br \/>\n3.  \u85ac\u5264\u8010\u6027\u5371\u6a5f\u306e\u4e0a\u6607\uff08CAGR\u3078\u306e\u5f71\u97ff: +1.2%\uff09: \u85ac\u5264\u8010\u6027\uff08AMR\uff09\u306f\u5e74\u9593\u63a8\u5b9a127\u4e07\u4eba\u306e\u6b7b\u4ea1\u3092\u5f15\u304d\u8d77\u3053\u3057\u3001\u5bfe\u7b56\u304c\u306a\u3051\u308c\u30702050\u5e74\u307e\u3067\u306b1,000\u4e07\u4eba\u306b\u9054\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002ESKAPE\u75c5\u539f\u4f53\u306f\u591a\u5264\u8010\u6027\u3092\u30a8\u30b9\u30ab\u30ec\u30fc\u30c8\u3055\u305b\u3066\u304a\u308a\u3001\u814e\u6bd2\u6027\u306e\u61f8\u5ff5\u304c\u3042\u308b\u306b\u3082\u304b\u304b\u308f\u3089\u305a\u3001\u30b3\u30ea\u30b9\u30c1\u30f3\u306a\u3069\u306e\u6700\u7d42\u624b\u6bb5\u306e\u9078\u629e\u80a2\u3092\u81e8\u5e8a\u533b\u306b\u5f37\u3044\u3066\u3044\u307e\u3059\u3002\u30ab\u30eb\u30d0\u30da\u30cd\u30e0\u8010\u6027\u30a2\u30b7\u30cd\u30c8\u30d0\u30af\u30bf\u30fc\u30fb\u30d0\u30a6\u30de\u30cb\u306f\u3001\u5358\u5264\u7642\u6cd5\u304c\u5931\u6557\u3057\u305f\u5f8c\u3001\u4f75\u7528\u7642\u6cd5\u3092\u5fc5\u8981\u3068\u3057\u3001\u6cbb\u7642\u8cbb\u3068\u8907\u96d1\u3055\u3092\u5897\u52a0\u3055\u305b\u3066\u3044\u307e\u3059\u3002<br \/>\n4.  \u65b0\u898f\u6297\u83cc\u85ac\u306b\u5bfe\u3059\u308b\u653f\u5e9c\u306e\u30b5\u30d6\u30b9\u30af\u30ea\u30d7\u30b7\u30e7\u30f3\u30a4\u30f3\u30bb\u30f3\u30c6\u30a3\u30d6\uff08CAGR\u3078\u306e\u5f71\u97ff: +0.4%\uff09: \u63d0\u6848\u3055\u308c\u3066\u3044\u308bPASTEUR\u6cd5\u306f\u3001\u53ce\u76ca\u3092\u91cf\u304b\u3089\u5207\u308a\u96e2\u3059\u8907\u6570\u5e74\u30b5\u30d6\u30b9\u30af\u30ea\u30d7\u30b7\u30e7\u30f3\u5951\u7d04\u3092\u627f\u8a8d\u3057\u3001\u91cd\u8981\u306a\u30cb\u30fc\u30ba\u306e\u3042\u308b\u6297\u83cc\u85ac\u958b\u767a\u8005\u306b\u3068\u3063\u3066\u4e88\u6e2c\u53ef\u80fd\u306a\u30ad\u30e3\u30c3\u30b7\u30e5\u30d5\u30ed\u30fc\u3092\u751f\u307f\u51fa\u3059\u3067\u3057\u3087\u3046\u3002BARDA\u306f2024\u5e74\u306b\u30bb\u30d5\u30c8\u30d3\u30d7\u30ed\u30fc\u30eb\u3084\u30b9\u30eb\u30d0\u30af\u30bf\u30e0\u30fb\u30c7\u30e5\u30eb\u30ed\u30d0\u30af\u30bf\u30e0\u3092\u542b\u3080\u8010\u6027\u5bfe\u7b56\u306b5\u5104\u7c73\u30c9\u30eb\u4ee5\u4e0a\u3092\u62e0\u51fa\u3057\u307e\u3057\u305f\u3002<br \/>\n5.  AI\u3092\u6d3b\u7528\u3057\u305f\u8fc5\u901f\u306a\u6297\u751f\u7269\u8cea\u767a\u898b\uff08CAGR\u3078\u306e\u5f71\u97ff: +0.3%\uff09: AI\u306e\u9032\u6b69\u306f\u3001\u5275\u85ac\u30d7\u30ed\u30bb\u30b9\u3092\u52a0\u901f\u3055\u305b\u3001\u65b0\u3057\u3044\u6cbb\u7642\u85ac\u306e\u7279\u5b9a\u3092\u652f\u63f4\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n6.  \u611f\u67d3\u76e3\u8996\u5206\u6790\u306e\u63a1\u7528\uff08CAGR\u3078\u306e\u5f71\u97ff: +0.2%\uff09: \u611f\u67d3\u76e3\u8996\u5206\u6790\u306e\u5c0e\u5165\u306f\u3001\u611f\u67d3\u75c7\u306e\u65e9\u671f\u767a\u898b\u3068\u7ba1\u7406\u3092\u6539\u5584\u3057\u3001\u6cbb\u7642\u85ac\u306e\u9700\u8981\u306b\u5f71\u97ff\u3092\u4e0e\u3048\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u5e02\u5834\u306e\u6291\u5236\u8981\u56e0<br \/>\n\u5e02\u5834\u306e\u6210\u9577\u3092\u6291\u5236\u3059\u308b\u4e3b\u306a\u8981\u56e0\u306f\u4ee5\u4e0b\u306e\u901a\u308a\u3067\u3059\u3002<br \/>\n1.  AMR\u306e\u52a0\u901f\u306b\u3088\u308b\u85ac\u5264\u52b9\u679c\u306e\u4f4e\u4e0b\uff08CAGR\u3078\u306e\u5f71\u97ff: -0.9%\uff09: \u30d0\u30f3\u30b3\u30de\u30a4\u30b7\u30f3\u8010\u6027\u8178\u7403\u83cc\u3084\u30e1\u30c1\u30b7\u30ea\u30f3\u8010\u6027\u9ec4\u8272\u30d6\u30c9\u30a6\u7403\u83cc\u306f\u3001\u96c6\u4e2d\u6cbb\u7642\u5ba4\u3067\u6839\u5f37\u3044\u8105\u5a01\u3067\u3042\u308a\u7d9a\u3051\u3066\u3044\u307e\u3059\u3002\u591a\u304f\u306e\u958b\u767a\u4e2d\u306e\u5019\u88dc\u85ac\u306fWHO\u306e\u512a\u5148\u75c5\u539f\u4f53\u306b\u5bfe\u51e6\u3057\u3066\u304a\u3089\u305a\u3001\u6cbb\u7642\u30ae\u30e3\u30c3\u30d7\u304c\u6b8b\u3063\u3066\u3044\u307e\u3059\u3002\u30bb\u30d5\u30bf\u30b8\u30b8\u30e0\u30fb\u30a2\u30d3\u30d0\u30af\u30bf\u30e0\u306e\u3088\u3046\u306a\u6700\u8fd1\u767a\u58f2\u3055\u308c\u305f\u4f75\u7528\u85ac\u306b\u5bfe\u3059\u308b\u8010\u6027\u3082\u3001\u5e02\u5834\u6295\u5165\u304b\u3089\u6570\u5e74\u3067\u65e2\u306b\u73fe\u308c\u3066\u3044\u307e\u3059\u3002<br \/>\n2.  \u9ad8\u3044\u958b\u767a\u30b3\u30b9\u30c8\u3068\u9577\u671f\u306b\u308f\u305f\u308b\u6cbb\u9a13\uff08CAGR\u3078\u306e\u5f71\u97ff: -0.5%\uff09: \u6297\u83cc\u85ac\u30d7\u30ed\u30b0\u30e9\u30e0\u306f\u3001\u7d0415\u5104\u7c73\u30c9\u30eb\u3068\u3044\u3046\u9ad8\u984d\u306a\u8cbb\u7528\u3068\u4e0d\u78ba\u5b9f\u306a\u30ea\u30bf\u30fc\u30f3\u306b\u76f4\u9762\u3057\u3066\u304a\u308a\u3001\u5927\u624b\u88fd\u85ac\u4f1a\u793e\u306e\u53c2\u52a0\u3092\u59a8\u3052\u3066\u3044\u307e\u3059\u3002\u91cd\u75c7\u611f\u67d3\u75c7\u306b\u304a\u3051\u308b\u30d7\u30e9\u30bb\u30dc\u4f7f\u7528\u306e\u502b\u7406\u7684\u5236\u9650\u306f\u3001\u30b5\u30f3\u30d7\u30eb\u8981\u4ef6\u3092\u81a8\u3089\u307e\u305b\u3001\u767b\u9332\u671f\u9593\u3092\u9577\u671f\u5316\u3055\u305b\u3066\u3044\u307e\u3059\u3002<br \/>\n3.  \u4e88\u9632\u6280\u8853\u306b\u3088\u308b\u85ac\u5264\u9700\u8981\u306e\u6291\u5236\uff08CAGR\u3078\u306e\u5f71\u97ff: -0.3%\uff09: \u611f\u67d3\u4e88\u9632\u6280\u8853\u306e\u666e\u53ca\u306f\u3001\u4e00\u90e8\u306e\u611f\u67d3\u75c7\u306b\u5bfe\u3059\u308b\u85ac\u5264\u9700\u8981\u3092\u6e1b\u5c11\u3055\u305b\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002<br \/>\n4.  \u6297\u751f\u7269\u8cea\u88fd\u9020\u306b\u95a2\u3059\u308b\u53b3\u3057\u3044\u6392\u51fa\u898f\u5236\uff08CAGR\u3078\u306e\u5f71\u97ff: -0.2%\uff09: \u53b3\u683c\u306a\u74b0\u5883\u6392\u51fa\u898f\u5236\u306f\u3001\u88fd\u9020\u30b3\u30b9\u30c8\u3092\u5897\u52a0\u3055\u305b\u3001\u5e02\u5834\u53c2\u5165\u306e\u969c\u58c1\u3068\u306a\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002<\/p>\n<p>\u30bb\u30b0\u30e1\u30f3\u30c8\u5206\u6790<\/p>\n<p>*   \u85ac\u5264\u30af\u30e9\u30b9\u5225: \u6297\u83cc\u85ac\u304c\u898f\u6a21\u3092\u7dad\u6301\u3057\u3001\u6297\u30a6\u30a4\u30eb\u30b9\u85ac\u304c\u52a0\u901f<br \/>\n    *   \u6297\u83cc\u85ac: \u4e16\u754c\u53ce\u76ca\u306e72.21%\u3092\u5360\u3081\u3066\u3044\u307e\u3059\u3002\u30bb\u30d5\u30c8\u30d3\u30d7\u30ed\u30fc\u30eb\u306e\u3088\u3046\u306a\u9759\u8108\u5185\u6295\u4e0e\u85ac\u306f\u3001\u9ec4\u8272\u30d6\u30c9\u30a6\u7403\u83cc\u83cc\u8840\u75c7\u306b\u5bfe\u3057\u306679.1%\u306e\u8907\u5408\u5fdc\u7b54\u7387\u3092\u793a\u3057\u3001\u03b2-\u30e9\u30af\u30bf\u30e0\u7cfb\u85ac\u5264\u306e\u81e8\u5e8a\u7684\u512a\u4f4d\u6027\u3092\u5f37\u5316\u3057\u3066\u3044\u307e\u3059\u3002\u4e2d\u56fd\u306e\u30b9\u30dd\u30f3\u30b5\u30fc\u306f\u73fe\u5728\u300120\u306e\u6297\u83cc\u85ac\u30d7\u30ed\u30b0\u30e9\u30e0\u3092\u81e8\u5e8a\u8a55\u4fa1\u4e2d\u3067\u3001\u4f9b\u7d66\u306e\u56de\u5fa9\u529b\u3068\u7af6\u4e89\u306e\u6fc0\u5316\u3092\u6df1\u3081\u3066\u3044\u307e\u3059\u3002<br \/>\n    *   \u6297\u30a6\u30a4\u30eb\u30b9\u85ac: \u73fe\u5728\u306f\u5c0f\u3055\u3044\u3082\u306e\u306e\u30013.83%\u306eCAGR\u3067\u6210\u9577\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u304a\u308a\u3001\u75c5\u9662\u306b\u7279\u5316\u3057\u305f\u6297\u30a6\u30a4\u30eb\u30b9\u85ac\u3084\u514d\u75ab\u8abf\u7bc0\u85ac\u306e\u666e\u53ca\u62e1\u5927\u3092\u53cd\u6620\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n    *   \u6297\u771f\u83cc\u85ac: \u30ab\u30f3\u30b8\u30c0\u8840\u75c7\u306b\u5bfe\u3059\u308b\u30ec\u30b6\u30d5\u30a1\u30f3\u30ae\u30f3\u306e\u627f\u8a8d\u306b\u3088\u308a\u6069\u6075\u3092\u53d7\u3051\u3066\u304a\u308a\u3001\u96c6\u4e2d\u6cbb\u7642\u306b\u304a\u3051\u308b\u90311\u56de\u6295\u4e0e\u306e\u9577\u5e74\u306e\u30ae\u30e3\u30c3\u30d7\u3092\u57cb\u3081\u3066\u3044\u307e\u3059\u3002<br \/>\n    *   \u305d\u306e\u4ed6: \u30d0\u30af\u30c6\u30ea\u30aa\u30d5\u30a1\u30fc\u30b8\u7642\u6cd5\u3084\u30e2\u30ce\u30af\u30ed\u30fc\u30ca\u30eb\u6297\u4f53\u7642\u6cd5\u304c\u542b\u307e\u308c\u3001\u5dee\u5225\u5316\u3055\u308c\u305f\u53ce\u76ca\u6e90\u3092\u8ffd\u52a0\u3059\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u304c\u3001\u88fd\u9020\u304a\u3088\u3073\u898f\u5236\u306e\u8907\u96d1\u3055\u3092\u89e3\u6c7a\u3059\u308b\u5fc5\u8981\u304c\u3042\u308a\u307e\u3059\u3002<\/p>\n<p>*   \u611f\u67d3\u30bf\u30a4\u30d7\u5225: \u8840\u6d41\u611f\u67d3\u75c7\u304c\u30ea\u30fc\u30c9\u3057\u3001\u624b\u8853\u90e8\u4f4d\u611f\u67d3\u75c7\u304c\u6025\u5897<br \/>\n    *   \u8840\u6d41\u611f\u67d3\u75c7: 2024\u5e74\u306b\u306f36.6\u5104\u7c73\u30c9\u30eb\u3092\u751f\u6210\u3057\u3001\u75c5\u9662\u611f\u67d3\u6cbb\u7642\u85ac\u5e02\u5834\u30b7\u30a7\u30a2\u306e30.65%\u3092\u5360\u3081\u307e\u3057\u305f\u3002\u65e9\u671f\u306e\u9759\u8108\u5185\u304b\u3089\u7d4c\u53e3\u3078\u306e\u5207\u308a\u66ff\u3048\u30d7\u30ed\u30c8\u30b3\u30eb\u306f\u3001\u6709\u52b9\u6027\u3092\u640d\u306a\u3046\u3053\u3068\u306a\u304f\u5165\u9662\u671f\u9593\u3092\u77ed\u7e2e\u3057\u3066\u3044\u307e\u3059\u304c\u3001\u9ad8\u3044\u6b7b\u4ea1\u7387\u304c\u30d7\u30ec\u30df\u30a2\u30e0\u85ac\u5264\u3078\u306e\u652f\u6255\u610f\u6b32\u3092\u7dad\u6301\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n    *   \u5c3f\u8def\u611f\u67d3\u75c7: \u7c73\u56fd\u3067\u306f\u5e74\u9593\u7d04360\u4e07\u4eba\u306e\u60a3\u8005\u304c\u7f79\u60a3\u3057\u3001626,000\u4ef6\u306e\u5165\u9662\u306b\u3064\u306a\u304c\u308a\u3001\u30b2\u30dd\u30c1\u30c0\u30b7\u30f3\u3084\u30d4\u30d6\u30e1\u30b7\u30ea\u30ca\u30e0\u306a\u3069\u306e\u7d4c\u53e3\u85ac\u306b\u5bfe\u3059\u308b\u7d99\u7d9a\u7684\u306a\u9700\u8981\u3092\u4fc3\u9032\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n    *   \u624b\u8853\u90e8\u4f4d\u611f\u67d3\u75c7\uff08SSI\uff09: \u75c5\u9662\u611f\u67d3\u6cbb\u7642\u85ac\u5e02\u5834\u5185\u3067\u6700\u901f\u306e3.54%\u306eCAGR\u3067\u5927\u5e45\u306b\u6210\u9577\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df\u306b\u304a\u3051\u308b\u6574\u5f62\u5916\u79d1\u304a\u3088\u3073\u810a\u690e\u624b\u8853\u306e\u5897\u52a0\u304c\u3053\u306e\u6210\u9577\u3092\u727d\u5f15\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n    *   \u80ba\u708e\uff08HAP\/VAP\uff09: \u75c5\u9662\u7372\u5f97\u6027\u80ba\u708e\u304a\u3088\u3073\u4eba\u5de5\u547c\u5438\u5668\u95a2\u9023\u80ba\u708e\u306f\u3001\u30a2\u30ba\u30c8\u30ec\u30aa\u30ca\u30e0\u30fb\u30a2\u30d3\u30d0\u30af\u30bf\u30e0\u306e\u3088\u3046\u306a\u65b0\u898f\u03b2-\u30e9\u30af\u30bf\u30de\u30fc\u30bc\u963b\u5bb3\u5264\u4f75\u7528\u85ac\u3092\u5fc5\u8981\u3068\u3057\u7d9a\u3051\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>*   \u6295\u4e0e\u7d4c\u8def\u5225: \u9759\u8108\u5185\u6295\u4e0e\u304c\u4f9d\u7136\u512a\u52e2\u3001\u7d4c\u53e3\u6295\u4e0e\u304c\u52e2\u3044\u3092\u5897\u3059<br \/>\n    *   \u9759\u8108\u5185\u6295\u4e0e: 2024\u5e74\u306e\u75c5\u9662\u611f\u67d3\u6cbb\u7642\u85ac\u5e02\u5834\u898f\u6a21\u306e44.95%\u3092\u5360\u3081\u307e\u3057\u305f\u3002\u30bb\u30d5\u30c8\u30d3\u30d7\u30ed\u30fc\u30eb\uff08667mg\u30926\uff5e8\u6642\u9593\u3054\u3068\u306b\uff09\u3084\u30bb\u30d5\u30a7\u30d4\u30e0\u30fb\u30a8\u30f3\u30e1\u30bf\u30be\u30d0\u30af\u30bf\u30e0\uff082.5g\u30928\u6642\u9593\u3054\u3068\u306b\uff09\u306e\u3088\u3046\u306a\u30ec\u30b8\u30e1\u30f3\u306f\u3001\u91cd\u75c7\u306e\u5165\u9662\u611f\u67d3\u75c7\u306e\u6a19\u6e96\u6cbb\u7642\u3067\u3042\u308a\u7d9a\u3051\u3066\u3044\u307e\u3059\u3002<br \/>\n    *   \u7d4c\u53e3\u6295\u4e0e: 2025\u5e74\u304b\u30892030\u5e74\u306b\u304b\u3051\u30664.13%\u306eCAGR\u3067\u6210\u9577\u3059\u308b\u3068\u4e88\u60f3\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u30b2\u30dd\u30c1\u30c0\u30b7\u30f3\u306e\u30d5\u30a1\u30fc\u30b9\u30c8\u30a4\u30f3\u30af\u30e9\u30b9\u306e\u30e1\u30ab\u30cb\u30ba\u30e0\u306f\u3001\u7b2cIII\u76f8\u5c3f\u8def\u611f\u67d3\u75c7\u6cbb\u9a13\u3067\u30cb\u30c8\u30ed\u30d5\u30e9\u30f3\u30c1\u30f3\u306b\u5bfe\u3059\u308b\u975e\u52a3\u6027\u3092\u793a\u3057\u3001\u7d4c\u53e3\u88fd\u5264\u306b\u304a\u3051\u308b\u65b0\u305f\u306a\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u3092\u793a\u5506\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n    *   \u305d\u306e\u4ed6: \u5674\u9727\u3001\u5c40\u6240\u3001\u7b4b\u8089\u5185\u306a\u3069\u306e\u7279\u6b8a\u306a\u9001\u9054\u30b7\u30b9\u30c6\u30e0\u304c\u542b\u307e\u308c\u3001\u30d0\u30a4\u30aa\u30d5\u30a3\u30eb\u30e0\u95a2\u9023\u30c7\u30d0\u30a4\u30b9\u6c5a\u67d3\u306a\u3069\u306e\u30cb\u30c3\u30c1\u306a\u611f\u67d3\u75c7\u3092\u30bf\u30fc\u30b2\u30c3\u30c8\u306b\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u5730\u57df\u5206\u6790<\/p>\n<p>*   \u5317\u7c73: 2024\u5e74\u306b\u306f\u75c5\u9662\u611f\u67d3\u6cbb\u7642\u85ac\u5e02\u5834\u306e\u4e16\u754c\u53ce\u76ca\u306e37.83%\u3092\u5360\u3081\u307e\u3057\u305f\u3002CDC\u306eNational Healthcare Safety Network\u306f\u3001HAI\u5831\u544a\u7fa9\u52d9\u5316\u653f\u7b56\u3092\u78ba\u7acb\u3057\u3001\u9ad8\u3044\u6cbb\u7642\u8b66\u6212\u3092\u7dad\u6301\u3057\u3066\u3044\u307e\u3059\u3002BARDA\u306e\u8cc7\u91d1\u63d0\u4f9b\u306f\u3001\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u8cc7\u7523\u306e\u8fc5\u901f\u306a\u5b9f\u7528\u5316\u3092\u652f\u3048\u3001\u30bb\u30d5\u30c8\u30d3\u30d7\u30ed\u30fc\u30eb\u3084\u30bb\u30d5\u30a7\u30d4\u30e0\u30fb\u30a8\u30f3\u30e1\u30bf\u30be\u30d0\u30af\u30bf\u30e0\u306a\u3069\u306e\u6700\u8fd1\u306eFDA\u627f\u8a8d\u306b\u3064\u306a\u304c\u3063\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u30a2\u30b8\u30a2\u592a\u5e73\u6d0b: 2030\u5e74\u307e\u3067\u306b\u4e3b\u8981\u5730\u57df\u306e\u4e2d\u3067\u6700\u901f\u306e4.53%\u306eCAGR\u3092\u8a18\u9332\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u4e2d\u56fd\u306e\u898f\u5236\u6539\u9769\u3068\u9769\u65b0\u7684\u533b\u85ac\u54c1\u56fd\u5bb6\u91cd\u70b9\u30d7\u30ed\u30b8\u30a7\u30af\u30c8\u306f\u300120\u306e\u6297\u83cc\u85ac\u6cbb\u9a13\u3092\u6301\u306417\u793e\u3092\u63a8\u9032\u3057\u3001\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u306e\u5e45\u3068\u56fd\u5185\u4fa1\u683c\u7af6\u4e89\u306b\u8ca2\u732e\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u30e8\u30fc\u30ed\u30c3\u30d1: GSK\u306e4,500\u4e07\u30dd\u30f3\u30c9\u306e\u30d5\u30ec\u30df\u30f3\u30b0\u30bb\u30f3\u30bf\u30fc\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u306e\u3088\u3046\u306a\u5354\u8abf\u7684\u306aAMR\u30a4\u30cb\u30b7\u30a2\u30c1\u30d6\u304b\u3089\u6069\u6075\u3092\u53d7\u3051\u3066\u3044\u307e\u3059\u3002\u6b27\u5dde\u533b\u85ac\u54c1\u5e81\u306b\u3088\u308b\u30a2\u30ba\u30c8\u30ec\u30aa\u30ca\u30e0\u30fb\u30a2\u30d3\u30d0\u30af\u30bf\u30e0\u3078\u306e\u80af\u5b9a\u7684\u306a\u610f\u898b\u306f\u3001\u30e1\u30bf\u30ed-\u03b2-\u30e9\u30af\u30bf\u30de\u30fc\u30bc\u7523\u751f\u83cc\u3092\u6a19\u7684\u3068\u3059\u308b\u521d\u306e\u03b2-\u30e9\u30af\u30bf\u30e0\/\u03b2-\u30e9\u30af\u30bf\u30de\u30fc\u30bc\u963b\u5bb3\u5264\u4f75\u7528\u85ac\u3067\u3042\u308a\u3001\u6cbb\u7642\u306e\u7a7a\u767d\u3092\u57cb\u3081\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u7af6\u4e89\u74b0\u5883<br \/>\n\u5e02\u5834\u306f\u4e2d\u7a0b\u5ea6\u306e\u96c6\u4e2d\u5ea6\u3092\u7dad\u6301\u3057\u3066\u3044\u307e\u3059\u3002Merck &#038; Co., Inc.\u3001F. Hoffmann-La Roche AG\u306a\u3069\u304c\u3001\u65e2\u5b58\u30d6\u30e9\u30f3\u30c9\u3068\u5f8c\u671f\u6bb5\u968e\u306e\u8cc7\u7523\u3092\u7d44\u307f\u5408\u308f\u305b\u3066\u6297\u83cc\u85ac\u30bb\u30b0\u30e1\u30f3\u30c8\u3092\u652f\u3048\u3066\u3044\u307e\u3059\u3002Roche\u306e\u30be\u30b9\u30e9\u30d0\u30eb\u30d4\u30f3\u306f\u73fe\u5728\u7b2c3\u76f8\u306b\u3042\u308a\u3001\u30ab\u30eb\u30d0\u30da\u30cd\u30e0\u8010\u6027\u30a2\u30b7\u30cd\u30c8\u30d0\u30af\u30bf\u30fc\u30fb\u30d0\u30a6\u30de\u30cb\u306b\u5bfe\u3059\u308b\u6570\u5341\u5e74\u6765\u521d\u306e\u65b0\u898f\u85ac\u5264\u3067\u3059\u3002Shionogi\u306b\u3088\u308bQpex Biopharma\u306e\u8cb7\u53ce\u306f\u3001\u30dc\u30ed\u30f3\u9178\u8a98\u5c0e\u4f53\u304a\u3088\u3073\u65b0\u898f\u03b2-\u30e9\u30af\u30bf\u30de\u30fc\u30bc\u963b\u5bb3\u5264\u3078\u306e\u30a2\u30af\u30bb\u30b9\u3092\u62e1\u5927\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>AI\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u304c\u5897\u52a0\u3057\u3066\u304a\u308a\u3001Eli Lilly\u3068OpenAI\u306e\u63d0\u643a\u306f\u30a4\u30f3\u30b7\u30ea\u30b3\u30ea\u30fc\u30c9\u751f\u6210\u306e\u52a0\u901f\u3092\u76ee\u6307\u3057\u3066\u3044\u307e\u3059\u3002Infex Therapeutics\u3084Centauri Therapeutics\u306e\u3088\u3046\u306a\u5c0f\u898f\u6a21\u306a\u5c02\u9580\u4f01\u696d\u306f\u3001\u591a\u5264\u8010\u6027\u75c5\u539f\u4f53\u306b\u5bfe\u3059\u308b\u514d\u75ab\u7642\u6cd5\u3001\u30da\u30d7\u30c1\u30c9\u3001\u30d5\u30a1\u30fc\u30b8\u30ab\u30af\u30c6\u30eb\u3092\u8ffd\u6c42\u3057\u3066\u3044\u307e\u3059\u3002\u74b0\u5883\u7ba1\u7406\u306f\u73fe\u5728\u3001\u7af6\u4e89\u4e0a\u306e\u5dee\u5225\u5316\u8981\u56e0\u3068\u306a\u3063\u3066\u304a\u308a\u3001Pfizer\u306fAMR Industry Alliance\u306e\u57fa\u6e96\u3092\u30b5\u30d7\u30e9\u30a4\u30e4\u30fc\u76e3\u67fb\u306b\u7d71\u5408\u3057\u3001\u6392\u51fa\u76ee\u6a19\u306b\u95a2\u3059\u308b\u9032\u6357\u72b6\u6cc1\u3092\u516c\u8868\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u30db\u30ef\u30a4\u30c8\u30b9\u30da\u30fc\u30b9\u306e\u6a5f\u4f1a\u3068\u3057\u3066\u306f\u3001\u7cbe\u5bc6\u8a3a\u65ad\u3068\u9023\u643a\u3057\u305f\u6cbb\u7642\u6cd5\u3001\u75c5\u9662\u306e\u7ba1\u7406\u3068\u9023\u643a\u3057\u305f\u30b5\u30d6\u30b9\u30af\u30ea\u30d7\u30b7\u30e7\u30f3\u5951\u7d04\u3001\u30d0\u30a4\u30aa\u30d5\u30a3\u30eb\u30e0\u304a\u3088\u3073\u30c7\u30d0\u30a4\u30b9\u95a2\u9023\u611f\u67d3\u75c7\u3092\u6a19\u7684\u3068\u3059\u308b\u4ee3\u66ff\u30e2\u30c0\u30ea\u30c6\u30a3\u306a\u3069\u304c\u6319\u3052\u3089\u308c\u307e\u3059\u3002\u3057\u304b\u3057\u3001\u5e02\u5834\u53c2\u5165\u4f01\u696d\u306f\u3001\u8cc7\u672c\u96c6\u7d04\u7684\u306a\u81e8\u5e8a\u30d7\u30ed\u30b0\u30e9\u30e0\u3068\u3001\u771f\u306e\u65b0\u898f\u6027\u3092\u512a\u5148\u3059\u308b\u9032\u5316\u3059\u308b\u511f\u9084\u653f\u7b56\u3092\u4e57\u308a\u8d8a\u3048\u308b\u5fc5\u8981\u304c\u3042\u308a\u307e\u3059\u3002\u5168\u4f53\u3068\u3057\u3066\u3001\u5b98\u6c11\u306e\u30a4\u30f3\u30bb\u30f3\u30c6\u30a3\u30d6\u304c\u8ca1\u653f\u30ea\u30b9\u30af\u3092\u4f4e\u6e1b\u3057\u3001AI\u304c\u767a\u898b\u306e\u30bf\u30a4\u30e0\u30e9\u30a4\u30f3\u3092\u77ed\u7e2e\u3059\u308b\u306b\u3064\u308c\u3066\u3001\u75c5\u9662\u611f\u67d3\u6cbb\u7642\u85ac\u5e02\u5834\u306b\u304a\u3051\u308b\u7af6\u4e89\u306f\u6fc0\u5316\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u4e3b\u8981\u4f01\u696d<br \/>\n*   AbbVie Inc.<br \/>\n*   Merck &#038; Co., Inc.<br \/>\n*   Teva Pharmaceutical Industries Ltd.<br \/>\n*   Viatris Inc.<br \/>\n*   F. Hoffmann-La Roche AG<\/p>\n<p>\u6700\u8fd1\u306e\u696d\u754c\u52d5\u5411<br \/>\n*   2025\u5e743\u6708: CARB-X\u306f\u3001\u4e16\u754c\u306e\u611f\u67d3\u75c7\u306e\u8105\u5a01\u3092\u30bf\u30fc\u30b2\u30c3\u30c8\u3068\u3057\u305f2025\u5e74\u306e\u8cc7\u91d1\u8abf\u9054\u30e9\u30a6\u30f3\u30c9\u3092\u958b\u59cb\u3057\u3001\u521d\u671f\u6bb5\u968e\u306e\u6297\u83cc\u85ac\u306b\u65b0\u305f\u306a\u52a9\u6210\u91d1\u3092\u5272\u308a\u5f53\u3066\u307e\u3057\u305f\u3002<br \/>\n*   2024\u5e742\u6708: FDA\u306f\u3001\u8907\u96d1\u6027\u5c3f\u8def\u611f\u67d3\u75c7\u306b\u5bfe\u3059\u308bExblifep\uff08\u30bb\u30d5\u30a7\u30d4\u30e0\/\u30a8\u30f3\u30e1\u30bf\u30be\u30d0\u30af\u30bf\u30e0\uff09\u3092\u627f\u8a8d\u3057\u300179.1%\u306e\u8907\u5408\u5fdc\u7b54\u7387\u3092\u793a\u3057\u307e\u3057\u305f\u3002<br \/>\n*   2023\u5e743\u6708: Hikma Pharmaceuticals PLC\u306f\u3001\u6ce8\u5c04\u7528\u30bb\u30d5\u30a1\u30be\u30ea\u30f3\u3092\u767a\u58f2\u3057\u307e\u3057\u305f\u3002\u3053\u306e\u85ac\u5264\u306f\u3001\u5c3f\u8def\u611f\u67d3\u75c7\u3001\u76ae\u819a\u3001\u547c\u5438\u5668\u3001\u5fc3\u81d3\u5f01\u819c\u3001\u95a2\u7bc0\u3001\u6027\u5668\u3001\u9aa8\u3001\u8840\u6db2\u3001\u80c6\u9053\u306a\u3069\u306e\u7279\u5b9a\u306e\u7d30\u83cc\u611f\u67d3\u75c7\u306e\u6cbb\u7642\u304a\u3088\u3073\u8853\u524d\u4e88\u9632\u3092\u76ee\u7684\u3068\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n*   2023\u5e741\u6708: Alkem\u306f\u3001\u30bb\u30d5\u30bf\u30b8\u30b8\u30e0\u3068\u30a2\u30d3\u30d0\u30af\u30bf\u30e0\u306e\u7d44\u307f\u5408\u308f\u305b\u3067\u3042\u308b\u6297\u751f\u7269\u8ceaZidavi\u3092\u767a\u58f2\u3057\u307e\u3057\u305f\u3002\u3053\u306e\u85ac\u5264\u306f\u3001\u75c5\u9662\u7372\u5f97\u6027\u80ba\u708e\uff08HAP\uff09\u304a\u3088\u3073\u8907\u96d1\u6027\u8179\u8154\u5185\u611f\u67d3\u75c7\uff08IAI\uff09\u306e\u7ba1\u7406\u3092\u76ee\u7684\u3068\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u3053\u306e\u30ec\u30dd\u30fc\u30c8\u306f\u3001\u9662\u5185\u611f\u67d3\u6cbb\u7642\u85ac\u5e02\u5834\u306b\u95a2\u3059\u308b\u8a73\u7d30\u306a\u5206\u6790\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002\u9662\u5185\u611f\u67d3\u6cbb\u7642\u85ac\u3068\u306f\u3001\u75c5\u9662\u306a\u3069\u306e\u533b\u7642\u65bd\u8a2d\u3067\u60a3\u8005\u304c\u611f\u67d3\u3059\u308b\u9662\u5185\u611f\u67d3\uff08HAIs\u307e\u305f\u306f\u30ce\u30bd\u30b3\u30df\u30a2\u611f\u67d3\uff09\u306e\u6cbb\u7642\u306b\u4f7f\u7528\u3055\u308c\u308b\u6297\u611f\u67d3\u75c7\u85ac\u3092\u6307\u3057\u307e\u3059\u3002\u3053\u308c\u3089\u306e\u611f\u67d3\u75c7\u306f\u3001\u65bd\u8a2d\u5185\u306e\u75c5\u539f\u4f53\u3001\u533b\u7642\u5668\u5177\u3001\u611f\u67d3\u60a3\u8005\u306a\u3069\u306b\u3088\u3063\u3066\u5f15\u304d\u8d77\u3053\u3055\u308c\u3001\u6cbb\u7642\u306b\u306f\u6297\u83cc\u85ac\u3001\u6297\u30a6\u30a4\u30eb\u30b9\u85ac\u3001\u6297\u771f\u83cc\u85ac\u306a\u3069\u304c\u7528\u3044\u3089\u308c\u307e\u3059\u3002<\/p>\n<p>\u5e02\u5834\u898f\u6a21\u3068\u6210\u9577\u4e88\u6e2c:<br \/>\n\u9662\u5185\u611f\u67d3\u6cbb\u7642\u85ac\u5e02\u5834\u306f\u30012025\u5e74\u306b119.1\u5104\u7c73\u30c9\u30eb\u3068\u8a55\u4fa1\u3055\u308c\u30012030\u5e74\u307e\u3067\u306b140.2\u5104\u7c73\u30c9\u30eb\u306b\u9054\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u5730\u57df\u5225\u5206\u6790:<br \/>\n\u73fe\u5728\u3001\u5317\u7c73\u304c\u5e02\u5834\u3092\u727d\u5f15\u3057\u3066\u304a\u308a\u3001\u4e16\u754c\u306e\u53ce\u76ca\u306e37.83%\u3092\u5360\u3081\u3066\u3044\u307e\u3059\u3002\u3053\u308c\u306f\u3001\u5805\u56fa\u306a\u8cc7\u91d1\u63d0\u4f9b\u3068\u53b3\u683c\u306a\u76e3\u8996\u4f53\u5236\u306b\u652f\u3048\u3089\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u85ac\u5264\u30af\u30e9\u30b9\u5225\u5206\u6790:<br \/>\n\u85ac\u5264\u30af\u30e9\u30b9\u5225\u3067\u306f\u3001\u6297\u83cc\u85ac\u304c2024\u5e74\u306e\u58f2\u4e0a\u9ad8\u306e72.21%\u3092\u5360\u3081\u3001\u5e83\u57df\u30b9\u30da\u30af\u30c8\u30eb\u85ac\u5264\u306b\u5bfe\u3059\u308b\u91cd\u8981\u306a\u9700\u8981\u304c\u305d\u306e\u6210\u9577\u3092\u5f8c\u62bc\u3057\u3057\u3066\u3044\u307e\u3059\u3002\u4e00\u65b9\u3001\u6297\u30a6\u30a4\u30eb\u30b9\u85ac\u306f\u3001\u65b0\u305f\u306a\u30a6\u30a4\u30eb\u30b9\u8010\u6027\u30d1\u30bf\u30fc\u30f3\u3068\u7cbe\u5bc6\u533b\u7642\u30a2\u30d7\u30ed\u30fc\u30c1\u306e\u9032\u5c55\u306b\u3088\u308a\u30012030\u5e74\u307e\u3067\u5e74\u5e73\u5747\u6210\u9577\u7387\uff08CAGR\uff093.83%\u3067\u6700\u3082\u901f\u3044\u6210\u9577\u3092\u9042\u3052\u308b\u3068\u898b\u8fbc\u307e\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u5e02\u5834\u306e\u63a8\u9032\u8981\u56e0:<br \/>\n\u5e02\u5834\u306e\u6210\u9577\u3092\u4fc3\u9032\u3059\u308b\u4e3b\u306a\u8981\u56e0\u3068\u3057\u3066\u306f\u3001\u9662\u5185\u611f\u67d3\u306e\u7f79\u60a3\u7387\u306e\u5897\u52a0\u3001\u5916\u79d1\u624b\u8853\u4ef6\u6570\u306e\u5897\u52a0\u3001\u85ac\u5264\u8010\u6027\uff08AMR\uff09\u5371\u6a5f\u306e\u6df1\u523b\u5316\u3001\u65b0\u898f\u6297\u751f\u7269\u8cea\u306b\u5bfe\u3059\u308b\u653f\u5e9c\u306e\u8cfc\u5165\u30a4\u30f3\u30bb\u30f3\u30c6\u30a3\u30d6\u3001AI\u3092\u6d3b\u7528\u3057\u305f\u8fc5\u901f\u306a\u6297\u751f\u7269\u8cea\u767a\u898b\u3001\u611f\u67d3\u76e3\u8996\u5206\u6790\u306e\u63a1\u7528\u304c\u6319\u3052\u3089\u308c\u307e\u3059\u3002<\/p>\n<p>\u5e02\u5834\u306e\u6291\u5236\u8981\u56e0:<br \/>\n\u4e00\u65b9\u3067\u3001\u5e02\u5834\u306e\u6210\u9577\u3092\u59a8\u3052\u308b\u8981\u56e0\u3082\u5b58\u5728\u3057\u307e\u3059\u3002\u5177\u4f53\u7684\u306b\u306f\u3001AMR\u306e\u52a0\u901f\u306b\u3088\u308b\u85ac\u5264\u52b9\u679c\u306e\u4f4e\u4e0b\u3001\u9ad8\u3044\u958b\u767a\u30b3\u30b9\u30c8\u3068\u9577\u671f\u306b\u308f\u305f\u308b\u6cbb\u9a13\u671f\u9593\u3001\u4e88\u9632\u6280\u8853\u306e\u9032\u6b69\u306b\u3088\u308b\u85ac\u5264\u9700\u8981\u306e\u6291\u5236\u3001\u6297\u751f\u7269\u8cea\u88fd\u9020\u306b\u95a2\u3059\u308b\u53b3\u3057\u3044\u6392\u51fa\u898f\u5236\u306a\u3069\u3067\u3059\u3002<\/p>\n<p>\u30ec\u30dd\u30fc\u30c8\u306e\u7bc4\u56f2\u3068\u30bb\u30b0\u30e1\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3:<br \/>\n\u672c\u30ec\u30dd\u30fc\u30c8\u3067\u306f\u3001\u5e02\u5834\u3092\u85ac\u5264\u30af\u30e9\u30b9\u5225\uff08\u6297\u83cc\u85ac\u3001\u6297\u771f\u83cc\u85ac\u3001\u6297\u30a6\u30a4\u30eb\u30b9\u85ac\u306a\u3069\uff09\u3001\u611f\u67d3\u75c7\u30bf\u30a4\u30d7\u5225\uff08\u8840\u6d41\u611f\u67d3\u75c7\u3001\u5c3f\u8def\u611f\u67d3\u75c7\u3001\u624b\u8853\u90e8\u4f4d\u611f\u67d3\u75c7\u3001\u80ba\u708e\u306a\u3069\uff09\u3001\u6295\u4e0e\u7d4c\u8def\u5225\uff08\u7d4c\u53e3\u3001\u9759\u8108\u5185\u306a\u3069\uff09\u3001\u304a\u3088\u3073\u5730\u57df\u5225\uff08\u5317\u7c73\u3001\u6b27\u5dde\u3001\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u3001\u4e2d\u6771\u30fb\u30a2\u30d5\u30ea\u30ab\u3001\u5357\u7c73\u306e\u4e3b\u8981\u5730\u57df\u3068\u3001\u305d\u306e\u4e2d\u306e17\u30ab\u56fd\uff09\u306b\u8a73\u7d30\u306b\u30bb\u30b0\u30e1\u30f3\u30c8\u5316\u3057\u3001\u5206\u6790\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u308c\u3089\u306e\u30bb\u30b0\u30e1\u30f3\u30c8\u306b\u3064\u3044\u3066\u3001\u7c73\u30c9\u30eb\u5efa\u3066\u306e\u5e02\u5834\u898f\u6a21\u3068\u30c8\u30ec\u30f3\u30c9\u304c\u63d0\u4f9b\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u7af6\u4e89\u74b0\u5883:<br \/>\n\u7af6\u4e89\u74b0\u5883\u306b\u3064\u3044\u3066\u306f\u3001\u5e02\u5834\u96c6\u4e2d\u5ea6\u3001\u5e02\u5834\u30b7\u30a7\u30a2\u5206\u6790\u3001\u304a\u3088\u3073AbbVie Inc.\u3001Merck &#038; Co., Inc.\u3001Pfizer Inc.\u3001Shionogi &#038; Co., Ltd.\u306a\u3069\u3001\u4e3b\u898122\u793e\u306e\u4f01\u696d\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\u304c\u8a73\u7d30\u306b\u8a18\u8ff0\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u5404\u4f01\u696d\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\u306b\u306f\u3001\u30b0\u30ed\u30fc\u30d0\u30eb\u304a\u3088\u3073\u5e02\u5834\u30ec\u30d9\u30eb\u306e\u6982\u8981\u3001\u4e3b\u8981\u30bb\u30b0\u30e1\u30f3\u30c8\u3001\u8ca1\u52d9\u60c5\u5831\uff08\u5165\u624b\u53ef\u80fd\u306a\u5834\u5408\uff09\u3001\u6226\u7565\u7684\u60c5\u5831\u3001\u4e3b\u8981\u4f01\u696d\u306e\u5e02\u5834\u30e9\u30f3\u30af\/\u30b7\u30a7\u30a2\u3001\u88fd\u54c1\u3068\u30b5\u30fc\u30d3\u30b9\u3001\u6700\u8fd1\u306e\u52d5\u5411\u304c\u542b\u307e\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u5e02\u5834\u6a5f\u4f1a\u3068\u5c06\u6765\u5c55\u671b:<br \/>\n\u30ec\u30dd\u30fc\u30c8\u306f\u307e\u305f\u3001\u5e02\u5834\u306b\u304a\u3051\u308b\u672a\u958b\u62d3\u306e\u9818\u57df\u3084\u6e80\u305f\u3055\u308c\u3066\u3044\u306a\u3044\u30cb\u30fc\u30ba\u306e\u8a55\u4fa1\u3092\u901a\u3058\u3066\u3001\u5c06\u6765\u306e\u5e02\u5834\u6a5f\u4f1a\u3068\u5c55\u671b\u306b\u3064\u3044\u3066\u3082\u8a00\u53ca\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts\/90145"}],"collection":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/comments?post=90145"}],"version-history":[{"count":1,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts\/90145\/revisions"}],"predecessor-version":[{"id":90148,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts\/90145\/revisions\/90148"}],"wp:attachment":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/media?parent=90145"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/categories?post=90145"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/tags?post=90145"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}